MPX International Corporation is a Canadian cannabis company focused on developing and operating cannabis assets around the world, with an emphasis on cultivation, manufacturing and product marketing.
Lexaria Bioscience Corp. develops and out-licenses its disruptive and cost-effective DehydraTECH™ technology, promoting healthier administration methods and lower overall dosing.
The company focuses on developing leading-edge options for curative and preventative therapies for diabetes and obesity, pain management, neurological disorders and cancer.
XORTX is a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease.
Richmond Club Investing Strategy
Since small-cap companies are volatile, Greg Beckett CIM, FCSI recommends the following:
- Buy a portfolio of 5-20 Richmond Club companies. To reduce risk and portfolio volatility, these stocks should be from three or more different sectors such as: healthcare, mining, oil & gas, software, technology, manufacturing, etc.
- Hold them for 1-5 years,
- Equally weight each stock in your portfolio by investing the same amount in each company,
- Rebalance your portfolio every 6-12 months. Rebalancing to maintain an equal weighting of each stock is a non-emotional discipline which forces you to “sell high and buy low”
- Consult your Investment Advisor before buying any stock.
Click here to see current stock offerings from Richmond Club Index companies
Click here to subscribe to Greg’s Stock Picks Newsletter
Click here to subscribe to the Richmond Club Youtube channel to be notified of new company interviews and presentations.